Compare Palo Alto Networks Inc (PANW) vs Twist Bioscience Corp (TWST) Price & Performance

Palo Alto Networks IncTrade

Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Palo Alto Networks Inc vs Twist Bioscience Corp — how do they compare? Palo Alto Networks Inc trades at $335.38 (market cap $278.85B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Palo Alto Networks Inc is far larger — about 46.7× Twist Bioscience Corp's market cap. Which is the better fit depends on your goals.

	PANW	TWST
Market Cap	$278.85B	$5.97B
Sector	Technology	Health
52-Week High	$358.68	$102.88
52-Week Low	$141.67	$24.16
Enterprise Value	$277.81B	$5.89B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PANW

Palo Alto Networks to acquire Embrace, adding Real User Monitoring and Synthetics to boost app performance insights.PRNewsWire · 1 day agoBullish Argus Research raises Palo Alto Networks price target to $425 on booming AI-driven cybersecurity demand.Danny Green · 1 day agoBullish Cybersecurity ETFs soar as investors shift from semiconductors amid rising cyber threats and AI risks.ETF Trends · 1 day agoBullish View details →

TWST

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 1 day agoNeutral View details →

About Palo Alto Networks Inc

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.